Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2024) 212 (4): 503.

IMMUNOLOGY NOTES AND RESOURCES

J Immunol (2024) 212 (4): 505–512.

BRIEF REVIEWS

J Immunol (2024) 212 (4): 513–521.

CUTTING EDGE

J Immunol (2024) 212 (4): 523–528.

  • SARS-CoV-2–induced mortality in K18-hACE2 mice is dependent on transgene dose.

  • Low hACE2 copy number mice exhibit reduced viral replication in the lung and brain.

  • One-copy hACE2 transgenic mice are an improved model of SARS-CoV-2 infection.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2024) 212 (4): 529–533.

  • Anti-rituximab Abs may cross-react to ocrelizumab, not to obinutuzumab or ofatumumab.

  • Obinutuzumab or ofatumumab is a safe alternative in case of Abs to rituximab.

IMMUNE SYSTEM DEVELOPMENT

J Immunol (2024) 212 (4): 534–540.

  • Augmenting Vβ rearrangement facilitates analysis of biallelic Tcrb gene assembly.

  • Cyclin D3 mediates TCRβ protein–signaled feedback inhibition of Vβ recombination.

J Immunol (2024) 212 (4): 541–550.

  • Alternatively spliced variants of CD3ζ affect T cell development and activation.

  • CD3ι-expressing T cells develop and activate normally, similar to cells expressing CD3ζ.

  • Mice reconstituted with CD3θ or CD3η have severe thymic defects.

IMMUNOTHERAPY AND VACCINES

J Immunol (2024) 212 (4): 551–562.

  • Ab-7 obtained by phage display library plays a favorable antiviral role.

  • Antigenic epitope ESQEFTTLTSH is pivotal in Ag–Ab binding.

  • Peptide vaccine KLH-G210–20 induces a strong and specific immune response.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2024) 212 (4): 563–575.

  • Asymptomatic MHV-1 dose provides protection to high-dose MHV-1 rechallenge.

  • Neutralizing Abs provide protection to high-dose viral challenge.

  • Sepsis, as a comorbidity, increases susceptibility to MHV-1 infection.

J Immunol (2024) 212 (4): 576–585.

  • Preclinical trial testing efficacy of RAGE-Ig for COVID-19 in mouse and hamster is reported.

  • Antiviral and anti-inflammatory therapeutic effects of RAGE-Ig were found for COVID-19.

J Immunol (2024) 212 (4): 586–595.

  • IL-2 sustains Th1 responses in the later stages of the antiviral response.

  • Differential exposure to IL-2 shapes the memory T cell compartment.

  • IL-2 is required to sustain Th1 responses even in the absence of TCF-1.

J Immunol (2024) 212 (4): 596–606.

  • Incomplete caspase-1 processing in hepatocytes is due to lower expression of ASC.

  • Enhancing ASC expression resulted in complete caspase-1 processing in hepatocytes.

  • This led to increased pyroptotic death in hepatocytes and better control of malaria.

J Immunol (2024) 212 (4): 607–616.

  • Schistosome infection impairs bone marrow HSC function after serial transplantation.

  • Infection blocks marrow erythropoiesis and increases spleen erythropoiesis.

  • Hematopoietic activity is increased in the livers of infected mice.

J Immunol (2024) 212 (4): 617–631.

  • Immunization with the GFP-DDDHA strain protects against secondary infection.

  • NK cells expand and develop a memory subset during immunization.

  • Memory NK cells rapidly proliferate and are highly cytotoxic in the recall response.

J Immunol (2024) 212 (4): 632–644.

  • CD4 T cells express CX3CR1 at the site of inflammation during helminth infection.

  • CD4 T cells that maintain CX3CR1 expression persist in the peripheral tissue.

  • CD4 T cells that express CX3CR1 are a transcriptionally heterogeneous population.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2024) 212 (4): 645–662.

  • OnCL-K1 significantly reduced the proliferation of pathogens.

  • OnCL-K1 associated with OnMASPs to initiate the lectin complement pathway.

  • OnCL-K1 promoted phagocytosis and killing of macrophages with OnCD93 interaction.

J Immunol (2024) 212 (4): 663–676.

  • CD13 is a negative regulator of macrophage fusion and giant cell formation.

  • Implant-induced FBGC formation and implant site fibrosis are increased in CD13KO mice.

  • CD13 controls fusogen expression and actin protrusion to regulate fusion.

J Immunol (2024) 212 (4): 677–688.

  • LPS stimulation induces CHTOP expression in microglia.

  • CHTOP regulates the expression of cell metabolism and inflammation-related genes.

  • Knockdown of CHTOP in microglia increased neuronal viability.

MOLECULAR AND STRUCTURAL IMMUNOLOGY

J Immunol (2024) 212 (4): 689–701.

  • A1 was identified as a candidate C1s binder through an artificial intelligence–based virtual screen.

  • A1 inhibits C1s dose-dependently with low micromolar potency in functional assays.

  • Structure of C1s inhibited by A1 suggests strategies for next-generation A1 analogs.

MUCOSAL IMMUNOLOGY

J Immunol (2024) 212 (4): 702–714.

  • The CMA-associated microbiota is enriched for LPS+ bacteria.

  • The CMA microbiota is associated with intestinal inflammation.

  • Proinflammatory responses in CMA-colonized mice depend on TLR4 in CD11c+ APCs.

TRANSPLANTATION

J Immunol (2024) 212 (4): 715–722.

  • IFN-β upregulates HLA-E and PD-L1 expression through the JAK/STAT/IRF7 pathway.

  • IFN-β–induced HLA-E protects HK-2 cells from allogeneic NK cell attack.

  • BDMC enhances IFN-β–induced HLA-E and PD-L1 expression in vitro and in vivo.

TUMOR IMMUNOLOGY

J Immunol (2024) 212 (4): 723–736.

  • The abnormal expression of METTL14 is related to glycolysis of tumor cells.

  • PD-1 expression in M2 macrophages is negatively correlated with phagocytosis.

  • Tumorous glycolysis might be the potential mechanism for the function of macrophages.

J Immunol (2024) 212 (4): 737–747.

  • HDACis directly promote expression of activation-associated genes in T cells.

  • In the TME, HDACis promote both T cell activation and exhaustion.

  • HDACis mediate expansion of immunosuppressive myeloid populations.

CORRECTIONS

J Immunol (2024) 212 (4): 748.
Close Modal

or Create an Account

Close Modal
Close Modal